Proving predictions wrong, health tech funding keeps climbing
SUCK ON THIS | GTFO or GTFO
stat
In reversal, Eli Lilly will now seek fast approval for Alzheimer's treatment
Pharmalittle: Lilly seeks speedy U.S. approval for its Alzheimer's drug
Two-thirds of Congress cashed a pharma campaign check in 2020
At Our Core
‘I'm just winging it’: Confusing Alzheimer's drug data cloud doctors' advice
On the frontier of gene therapy, new possibilities emerge
FDA grants historic approval to Alzheimer’s drug from Biogen
Moderna hits safety problems in bold bid to reinvent medicine
Virtual Event - Biotech: Where are we now?
Sage antidepressant achieves goals of study, but questions linger
GSK buys rights to TIGIT-targeted cancer immunotherapy from Iteos
CRISPR treatment for blood diseases shows promise in small study
In potential big step, Bristol says CAR-T outperformed stem cell transplant
SPACs are all the rage, but what are they? STAT explains
Biogen, FDA at odds over timing of confirmatory trial of Alzheimer’s drug
Biogen isn’t worried about backlash to price of Alzheimer’s drug
STAT+ Conversations: Discussing Biogen’s Alzheimer’s drug
Biogen’s big day is a Wall Street windfall for biotechs in Alzheimer’s
Why Biogen may have the most lucrative product in pharmaceutical history
With Alzheimer's drug, the FDA is shifting its rules. That is a giant risk
FAQs: What you need to know about the Alzheimer’s drug Aduhelm
Biotech, health startups bet on a strange new reality show for crowdfunding
Anaplastic
Anaplasia - an overview | ScienceDirect Topics
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
The Global Anaplastic Lymphoma Kinase (ALK) Inhibitors Market is expected to grow by $ 3.43 billion during 2021-2025, progressing at a CAGR of almost 22% during the forecast period
Features of Anaplastic Cells
Anaplastic